[Sandimmun Optoral now approved in Germany. Treatment of rheumatoid arthritis].
D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D016572:Cyclosporine / Q000627:therapeutic use*; D017277:Drug Approval; D004338:Drug Combinations; D005858:Germany; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use*
D004338:Drug Combinations; D016572:Cyclosporine; D008727:Methotrexate
Sandimmun Optoral jetzt auch in Deutschland zugelassen. Behandlung von rheumatoider Arthritis.